Microscopic landscape with Raoultella Planticola bacterium at a crossroads

UTI Breakthrough: How a Rare Infection is Changing Post-Op Care

"Discover the emerging threat of Raoultella Planticola UTIs after surgery and how doctors are adapting their treatment strategies to protect vulnerable patients."


Urinary tract infections (UTIs) are a common health issue, but what happens when a rare and unexpected bacteria is the cause? Raoultella Planticola, a gram-negative bacterium typically found in water and soil, is emerging as a concerning source of UTIs, especially following surgical procedures. This article explores this unusual infection, its risk factors, and how healthcare professionals are adapting their approaches to protect patients.

Traditionally, Raoultella Planticola was classified under the Klebsiella genus but has since been reclassified based on genetic sequencing. While it's not usually a threat to human health, there have been increasing reports of severe infections linked to this bacterium since the first recorded case of sepsis in 1984. Most of these cases involve bacteremia, a bloodstream infection, making the recent discovery of UTIs caused by Raoultella Planticola particularly noteworthy.

This article will delve into a specific case of a patient who developed a Raoultella Planticola UTI after undergoing a hysterectomy, examining the potential risk factors and treatment strategies employed. Additionally, it will review existing literature to provide a comprehensive understanding of this rare infection and its implications for post-operative care.

AI Search Multiple angles on this topic

Portland’s BIKETOWN Network

BIKETOWN is Portland Bureau of Transportation’s bike-share program, operated by Lyft and sponsored by NIKE, Inc. Portland.gov also identifies Adaptive BIKETOWN rentals for people with disabilities and BIKETOWN for All, which provides affordable options for people living on low incomes. The service is promoted for commuting, errands, appointments, and other trips around the city.

Established Approaches

The supplied material does not provide sources describing standard UTI treatment methods or their limitations. In general, established clinical approaches are typically evaluated against patient safety, diagnostic accuracy, and treatment effectiveness. Without subsection-specific evidence, no particular method or limitation can be presented as supported here.

Historical Foundations

The supplied material does not document milestones or foundational discoveries related to UTIs or post-operative care. A reliable historical account would require sources addressing the development of diagnosis, antimicrobial treatment, or infection-control practices. Those details cannot be established from the provided material.

The Case: A Post-Operative UTI Surprise

Microscopic landscape with Raoultella Planticola bacterium at a crossroads

A 50-year-old woman with a history of lupus, dysphagia, degenerative disc disease, and peripheral neuropathy underwent a total vaginal hysterectomy with several related procedures to address a stage 4 utero-vaginal prolapse. Her pre-existing condition of lupus required her to take methotrexate, an immunosuppressant, before surgery.

Post-operatively, the patient faced some initial difficulties, including being unable to urinate, which required her to be discharged with a Foley catheter. While she eventually passed a void trial a few days later, she presented two weeks later with lower quadrant pain and some unusual discharge. A urinalysis revealed the presence of blood, nitrites, and a high level of leukocyte esterase, indicating an infection.

  • Diagnosis: The urine culture confirmed the presence of Raoultella Planticola, sensitive to most antibiotics but resistant to Tetracycline.
  • Treatment: She was prescribed Nitrofurantoin to combat the infection.
  • Outcome: Following the antibiotic treatment, her symptoms resolved, and a repeat urine culture showed no further bacterial growth.
AI Search Multiple angles on this topic

What the Sources Actually Show

The supplied research material primarily concerns bamboo and BambooHR rather than UTI research. Britannica describes bamboo as the Bambusoideae subfamily of grasses, comprising more than 115 genera and 1,400 species. Separately, BambooHR presents custom dashboards, HR benchmarks, and an intelligence layer for business decisions, while its login page describes employee-data and paid-time-off management.

A Documented Case of Infection

The supplied sources do not describe clinical trials, failed UTI interventions, or competing post-operative-care strategies. They do document Hugh Hefner’s public biography: he founded and edited Playboy magazine, which began with its first issue featuring Marilyn Monroe in December 1953. A Simple English Wikipedia entry reports that Hefner died in Beverly Hills on September 27, 2017, after cardiac arrest and sepsis associated with respiratory failure and an E. coli infection; this is a biographical account, not evidence about UTI treatment.

Operational Comparison Not Supported

The supplied sources concern Summit Racing customer-service operations rather than UTI care. Its Order Status Lookup can check a pending order, cancel a pending order, provide tracking information, support returns or exchanges, and reprint certain labels. Because the material does not compare medical treatments, no clinical comparative conclusion can be drawn.

This case highlights the potential for unusual pathogens to cause post-operative infections, particularly in individuals with compromised immune systems. It also emphasizes the importance of thorough testing and appropriate antibiotic selection to ensure effective treatment.

Adapting to Emerging Pathogens

The rise of Raoultella species as significant pathogens requires increased vigilance and awareness among healthcare providers. Cystitis, or bladder infection, is the most common type of infection associated with R. Planticola. A five-year review indicated that 50% of Raoultella Planticola infections were UTIs. Beyond UTIs, this bacterium has been linked to a range of other infections, including septicemia, pneumonia, and surgical site infections. Immunosuppression, invasive procedures, and contaminated equipment appear to be significant risk factors.

AI Search Multiple angles on this topic

Technology and Organizational Scale

The supplied sources describe Microsoft as a multinational technology company headquartered in Redmond, Washington. They identify its areas of activity as including Windows, internet services, cloud computing, artificial intelligence, video gaming, and other technologies. Microsoft’s current product materials also feature Microsoft 365, Copilot, Teams, Xbox, Windows, Azure, and Surface, but these sources do not provide expert commentary on UTI care.

Evidence Needed for Future Directions

The supplied material does not contain projections or research findings about the future of UTI diagnosis, infection prevention, or post-operative care. Future claims would require evidence from clinical studies, implementation research, or authoritative health-system guidance. Without those sources, specific next frontiers cannot be identified responsibly.

Energy-System Context

The supplied sources address U.S. electricity generation rather than health-care systems. The U.S. Energy Information Administration provides historical nuclear-generation data from 1957 through the latest available final data and publishes the Annual Energy Outlook 2026. The American Public Power Association describes nearly 1.4 terawatts of U.S. utility-scale generation capacity, while one 2026 nuclear-facility listing reports 124 facilities: 54 active, 3 restart-pending, 27 in development, and 40 decommissioned.

Patient Impact Requires Direct Evidence

The supplied material does not include patient accounts, caregiver perspectives, or outcome data related to UTIs and post-operative care. A meaningful discussion of human impact would need evidence about symptoms, recovery, access to treatment, or quality of life. Those issues cannot be described specifically from the listed sources.

What the reported case counts represent

  • 6 of 32 reported serious casesAmong 32 serious Raoultella infections reported from 1984 to 2018, 6 involved UTIs. These are counts within published serious cases, not an estimate of how often UTIs occur among patients.[1]

Where the Raoultella evidence is weakest

  • The authors could not identify the exposure source in their case and raised cross-contamination only as a possibility.[1]

The study at a glance

PopulationA 50-year old woman with lupus and a medical history of dysphagia, degenerative disc disease with lumbar-sacral spinal stenosis, and peripheral neuropathy[2]
Main outcomeUTI with Raoultella Planticola[2]
Times cited18[2]

How this case fits among reported urinary infections

In the 2019 review’s six urinary cases, four were attributed to immunosuppression; this is a description of reviewed cases, not proof that immunosuppression caused infection.[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.eucr.2018.11.004, Alternate LINK

Title: Urinary Tract Infection With Rare Pathogen Raoultella Planticola: A Post-Operative Case And Review

Subject: Urology

Journal: Urology Case Reports

Publisher: Elsevier BV

Authors: Charlotte Fager, Ladin Yurteri-Kaplan

Published: 2019-01-01

Everything You Need To Know

1

What is Raoultella Planticola, and why is it a concern in post-operative care?

Raoultella Planticola is a gram-negative bacterium, typically found in water and soil, that is emerging as a concerning cause of urinary tract infections (UTIs), particularly after surgical procedures. Unlike common bacteria, Raoultella Planticola is rare but can cause significant health issues, including bacteremia (bloodstream infection). Its emergence as a post-operative concern is due to its potential to infect patients, especially those with compromised immune systems or after invasive procedures, making it a significant factor in post-operative care.

2

What are the main risk factors associated with Raoultella Planticola UTIs?

The primary risk factors for Raoultella Planticola UTIs include immunosuppression, invasive procedures, and the potential use of contaminated equipment. Immunosuppression weakens the body's defenses, making it easier for the bacteria to establish an infection. Invasive procedures, like the hysterectomy mentioned in the case study, provide an entry point for the bacteria. The use of contaminated equipment can directly introduce the bacteria into the patient's system, leading to infection. Patients with underlying health conditions like lupus, as seen in the provided example, are at higher risk due to the immunosuppressive medications they may take.

3

How does Raoultella Planticola differ from other bacteria causing UTIs?

Unlike more common bacteria associated with UTIs, such as E. coli, Raoultella Planticola is a rare pathogen, which presents unique challenges in diagnosis and treatment. Initially classified within the Klebsiella genus, it was reclassified due to genetic sequencing. This bacterium's resistance profile can differ, as seen in the case where it was resistant to Tetracycline but sensitive to Nitrofurantoin. Its rarity means healthcare providers must be vigilant and aware of its potential presence, especially in post-operative settings. This includes the need for thorough testing and appropriate antibiotic selection to ensure effective treatment.

4

What treatment strategies are typically used to combat Raoultella Planticola UTIs?

Treatment for Raoultella Planticola UTIs typically involves antibiotics to which the bacteria is sensitive. The case study highlights the use of Nitrofurantoin as an effective treatment, while the bacteria showed resistance to Tetracycline. Due to the varying antibiotic sensitivities, accurate identification and culture sensitivity testing are crucial to guide treatment. The goal is to eradicate the infection and prevent complications such as sepsis. Healthcare providers must consider the patient's overall health, existing medications, and any potential drug interactions when prescribing antibiotics.

5

Can you explain the importance of the case of the 50-year-old woman with Raoultella Planticola UTI after a hysterectomy, and its implications?

The case of the 50-year-old woman who developed a Raoultella Planticola UTI after a hysterectomy is important because it underscores the potential for rare pathogens to cause post-operative infections, particularly in individuals with compromised immune systems. Her pre-existing conditions such as lupus, dysphagia, degenerative disc disease, and peripheral neuropathy, alongside taking methotrexate, a medication that suppresses the immune system, increased her vulnerability. The diagnosis, treatment with Nitrofurantoin, and successful outcome highlight the importance of recognizing the emergence of Raoultella Planticola as a pathogen and adapting treatment strategies accordingly. It emphasizes the need for thorough testing, appropriate antibiotic selection, and increased vigilance among healthcare providers to safeguard patients, especially those undergoing surgical procedures.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.